PET-Directed Therapy with ABVD Vs. Bv+AVD Followed By Nivolumab in Patients with Early Stage Hodgkin Lymphoma: A Propensity Score Matched Analysis of CALGB50604 and ACCRULY1601
Year: 2024
Type: conference-abstract
Source: Blood
Institutions: Levine Cancer Institute, Mayo Clinic, Abramson Cancer Center, University of Pennsylvania, University of Washington, Fred Hutch Cancer Center, Hackensack Meridian Health, City Of Hope National Medical Center, City of Hope, University of Nebraska at Omaha, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405042813